Clinical Trials Directory

Trials / Unknown

UnknownNCT04018105

Influence of Preprandial Metformin Administration on Carbohydrate Absorption

Influence of Preprandial Metformin Administration on Carbohydrate Absorption: Pilot Randomized Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Type 2 diabetes is spreading worldwide as well as obesity. Metformin is the most prescribed antidiabetic medication. One suggested mechanism of action is by decreasing carbohydrate absorption. It is usually recommended to take metformin during the meal to decrease gastrointestinal side effects. However, if metformin decreases carbohydrate absorption, this might not be the most efficient intake. To study the influence of preprandial metformin administration on carbohydrate absorption, it will repeat 3 oral glucose tolerance test on obese dysglycemic patients, without metformin or with metformin administer 30 or 60 minutes before. We will also evaluate how it impacts gastrointestinal tolerance.

Conditions

Interventions

TypeNameDescription
OTHEROral glucose tolerance test (OGTT) with or without metforminEach participant will have 3 OGTT, one without metformin, one with metformin30 minutes before the test, one with metformin 60 minutes before the test. The order for each test will be randomized.

Timeline

Start date
2022-12-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2019-07-12
Last updated
2022-08-19

Source: ClinicalTrials.gov record NCT04018105. Inclusion in this directory is not an endorsement.